Search Orphan Drug Designations and Approvals
-
Generic Name: | doxorubicin |
---|---|
Date Designated: | 04/06/2015 |
Orphan Designation: | Treatment of cutaneous T-cell lymphoma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Louis D. Falo, Jr. University of Pittsburgh, Dep. of Dermatology 3500 Fifth Avenue Pittsburgh, Pennsylvania 15213 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-